Cambrex Corp. Daily Stock Analysis

Daily Stock Analysis, CBM, Cambrex Corp, priceseries

Cambrex Corp. Daily Stock Analysis
Stock Information
Open
59.99
Close
59.99
High
59.99
Low
59.98
Previous Close
59.99
Daily Price Gain
0.00
YTD High
69.42
YTD High Date
Sep 28, 2018
YTD Low
1.48
YTD Low Date
Mar 6, 2009
YTD Price Change
46.74
YTD Gain
352.87%
52 Week High
59.99
52 Week High Date
Dec 3, 2019
52 Week Low
59.38
52 Week Low Date
Oct 2, 2019
52 Week Price Change
0.49
52 Week Gain
0.82%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Mar 28. 2017
51.40
Apr 12. 2017
55.49
11 Trading Days
7.96%
Link
LONG
Jun 1. 2017
54.85
Jul 5. 2017
58.99
23 Trading Days
7.55%
Link
LONG
Jan 16. 2018
53.00
Feb 1. 2018
55.86
12 Trading Days
5.39%
Link
LONG
Jun 21. 2018
47.20
Aug 10. 2018
61.63
35 Trading Days
30.57%
Link
LONG
Jan 3. 2019
39.14
Jan 15. 2019
42.76
8 Trading Days
9.26%
Link
LONG
Jun 6. 2019
41.34
Jul 9. 2019
46.01
22 Trading Days
11.30%
Link
Company Information
Stock Symbol
CBM
Exchange
NYSE
Company URL
http://www.cambrex.com
Company Phone
2018043000
CEO
Steven M. Klosk
Headquarters
New Jersey
Business Address
ONE MEADOWLANDS PLZ, E RUTHERFORD, NJ 07073
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0000820081
About

Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in December 1981 and is headquartered in East Rutherford, NJ.

Description

Cambrex Corporation, a life sciences company, provides various products and services for the development and commercialization of new and generic therapeutics worldwide. The company's products comprise active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products, as well as other fine chemicals. It serves generic drug companies; and companies that discover and commercialize small molecule human therapeutics. The company sells its products directly, as well as through independent agents. Cambrex Corporation was founded in 1981 and is headquartered in East Rutherford, New Jersey.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading